- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
OneSource Specialty Pharma Ltd is in the research, development, manufacture and commercialisation of bio logical drug products in various injectable formats. It also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologicsBusiness Overview: OSSPL is a subsidiary of Strides Pharma Ltd. The...
The provided document is an "Intimation of Investor Presentation," which announces that an investor meeting was held and the investor presentation has been uploaded to the company's website. As the actual content of the investor presentation (details on business performance, growth drivers, financials, etc.) is not included in this document,...
OneSource Specialty Pharma's FY26 BRSR shows improved environmental performance with major NOx/SOx emission cuts and enhanced energy/water efficiency from new systems. Accounts payable days doubled to 163.75, while related party sales share dropped to 29.12%. CSR spend reached ₹2.15 Cr.
OneSource Specialty Pharma Limited will host a physical Group Investor Meeting on Thursday, September 03, 2026, at its Manufacturing Facility in Doddaballapura. Company representatives will discuss the business overview, strategy, industry trends, and growth outlook during the meeting. No unpublished price sensitive information will be shared.